From my perspective, I guess the CDR is really looking at bringing new drugs onto the market. It provides us with information on whether or not a particular drug is more cost-effective than anything else out there.
If I step back to where we were before 2003, it was taking a lot longer to get decisions made on whether or not a drug would be added to one of our drug plans, for example, because we didn't really have the expertise. Instead of it taking 300 days, it could've taken 600 days. I don't know the actual number, because we would have to try to get the information ourselves. The timeframes have actually come down dramatically. The benefit for the pharmaceutical companies is that they don't have to come to each one of us individually to try to make the case. They can make the case in front of a common drug review.